Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
5 hedge funds and large institutions have $263K invested in Genetic Technologies Ltd. in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $223K → $263K (+$39.9K)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less funds holding
Funds holding: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$34.4K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $259K | +$34.4K | +3,523 | +16% |
|
|
CG
2
Cutler Group
San Francisco,
California
| $2K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | -$6.23K | -638 | -91% |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$1.95K | +200 | New |
|
|
RE
5
RBC Europe
London,
United Kingdom
| $40 | – | – | – |
|
GENE Hedge Fund Activity: Q4 2019 in Review
5 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2019, worth a combined $263K — up 18% from $223K a quarter earlier.
Fund positioning in GENE was balanced in Q4 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $34.4K. The largest seller was UBS Group, cutting an estimated $6.23K.
- 5 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2019, down from 6 in Q3 2019.
- Funds reported $263K of Genetic Technologies Ltd. stock for Q4 2019, up 18% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q4 2019 and 1 closed out, a net change of 0 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2019 was Renaissance Technologies, an estimated $34.4K added.
- The largest Genetic Technologies Ltd. seller in Q4 2019 was UBS Group, an estimated $6.23K sold.
Based on aggregated 13F filings for Q4 2019.